The Small ubiquitin-related modifier (SUMO) conjugation to a variety of proteins regulates diverse cellular processes, including transcription, cell cycle regulation and maintenance of genome integrity. To investigate in vivo biological function of SUMO paralogs, we inactivated them in the early development of zebrafish. While zebrafish embryos deficient for all three SUMO paralogs, as Ubc9-deficient ones, displayed severe defects, loss of individual SUMO paralog was compatible with a normal development. SUMO-deficient embryos can be rescued by a single human or zebrafish SUMO. While key structural basic lysine residues and N-terminal unstructured stretch of SUMO are critical for in vivo rescue, the consensus K11 sumoylation site of SUMO2 is dispensable, implying that chain formation on this potential site is unessential for normal development. Inactivation of all three SUMOs triggered p53-dependent apoptosis and further inactivation of p53 restored normal zebrafish development. Interestingly, we also demonstrate that the dominant negative truncated form of p53, Δ113p53, significantly blunts SUMO depletion-induced p53 activity in vivo. Taken together, our results suggest that SUMO paralogs are indispensable, but redundant, in the early development of zebrafish.
Introduction
The small ubiquitin-related modifier (SUMO) is highly conserved through evolution, and belongs to the growing family of ubiquitin-like proteins (UBLs) involved in posttranslational protein modification. SUMO conjugation is carried out by a multistep enzymatic pathway consisting of a unique heterodimeric SUMO-activating enzyme (E1), Aos1/Uba2, a unique SUMO-conjugating enzyme (E2), Ubc9, and three families of SUMO ligase (E3), which eventually attach SUMO to the substrates [1] [2] [3] [4] . Protein sumoylation plays important roles in a wide variety of biological processes such as transcriptional regulation, maintenance of genome integrity and subcellular localization [5] [6] [7] [8] [9] .
The sumoylation pathway is conserved from yeast to human. Four SUMO paralogs, SUMO1, SUMO2, SU-MO3 and SUMO4, exist in mammals. While SUMO2, SUMO3 and SUMO4 share high homology with each other [10] , SUMO1 consists of 101 amino acids and shares about 50% sequence identity with SUMO2, SU-MO3, SUMO4 and 18% with ubiquitin. In mammalian cells, different SUMO paralogs appear to share common conjugation properties, but also have some specificities, such as subcellular distribution and substrate preferences. For instance, it is reported that, within cells, there is a larger pool of free, non-conjugated SUMO2/3 than that of SUMO1 [11] . The distribution of the SUMO paralogs within cells also seems to be different. SUMO1 is found within the nucleoli, the nuclear envelope and cytoplasmic foci, whereas SUMO2/3 are dominant on chromosomes. Moreover, while the expression of SUMO1 and SUMO2/3 is ubiquitous, SUMO4 is found predominantly in kidney and immune system [10, 12] . The conjugation of SUMO2/3 to substrates is usually induced when the cells are subjected to protein-damaging stimuli, such as acute temperature fluctuation, suggesting a role for SUMO2/3 in the cellular responses to environmental stress [11] . Covalent conjugation of SUMO4 to substrates is still under debate [13, 14] . Finally, for some substrates, strong paralog preferences have been reported. For instance, promyelocytic leukemia protein (PML) could be conjugated to all three SUMO paralogs [15, 16] . RanGAP1 is preferentially modified by SUMO1 [11] , and topoisomerase II is sumoylated by SUMO2/3 during mitosis [17] .
In most model organisms, loss of Ubc9 leads to severe defects and lethality [18] [19] [20] [21] [22] [23] . However, the respective biological impact of each SUMO paralog is poorly explored in vivo. It is known that SUMO is required for normal embryonic development in the organisms with one single SUMO gene [20, 24] . More recently, it has been reported that SUMO1 is dispensable in mouse development [25] , but the importance of SUMO2/3 in vivo is unknown. Here, we have investigated the functional role of SUMO paralogs during the early embryonic development of zebrafish. We found that all three SUMOs were maternally provided and ubiquitously expressed at early developmental stages. While the maternally supplied SUMO proteins may still be sufficient to carry out essential functions for cell viability during early hours of embryonic development, loss of zygotic SUMO paralogs by antisense morpholino oligonucleotides (MOs) causes severe embryonic developmental defects. Further analysis reveals that cells undergoing p53-dependent apoptosis may account for the SUMO deficiency-triggered developmental defects.
Results

Spatial and temporal expression patterns of SUMO paralogs during zebrafish early embryonic development
Three SUMO paralogs of zebrafish were identified via bioinformatic searching. Zebrafish SUMO paralogs and Ubc9 share high homology with their human counterparts ( Figure 1A ). Their embryonic expression was examined by whole-mount mRNA in situ hybridization. Similar spatial and temporal expression patterns were found for all three SUMO paralogs and Ubc9 ( Figure  1B and Supplementary information, Figure S1 ). All three SUMO transcripts could be detected throughout all investigated stages, including one-cell stage ( Figure  1B, a1-3 ), indicating that they were both maternally and zygotically supplied. During cleavage ( Figure 1B, b1-3) , blastula ( Figure 1B, c1-3 ), gastrula ( Figure 1B , d1-3 and e1-3) and early segmentation stages (data not shown), the three SUMO transcripts were ubiquitously expressed throughout the entire embryo. At 24 hours post-fertilization (hpf), expression was dominant in the head region, including brain, eyes, cranial neural crest cells ( Figure  1B , f1-3 and g1-3), which are known as late proliferative zones. Double staining with neural crest marker dlx2a [26] confirmed that the three SUMOs were specifically expressed within this region ( Figure 1B, h1-3 ). At 48-hpf, expression became further restricted to late proliferative zones. While expression was found in pectoral fin buds, it was much weaker within the regions of trunk and tail ( Figure 1B, i1-3 ). At 72-hpf, expression had decreased in most tissues except in the branchial arches and the digestive organs ( Figure 1B, j1-3) .
Loss of SUMO expression leads to developmental defects
To study loss of functions of zebrafish SUMO paralogs during early embryonic development, SUMO paralog-specific MOs were injected individually or in different combinations at one-cell stage, and specific rescue experiments were performed in parallel. Injected embryos were followed until 7 days post-fertilization (dpf). The efficacy of each SUMO paralog-specific MO was first tested with a SUMO-EGFP reporter (Supplementary information, Figure S2A ) and further confirmed by the diminution of endogenous SUMOs and Ubc9 proteins (Supplementary information, Figure S2B ). Individual loss of SUMO1, SUMO2 and SUMO3, or pairwise loss of SUMO1 and SUMO2 had no overt phenotype (Supplementary information, Table S1 ). Severe developmental defects, similar to those observed in Ubc9-deficient embryos, were found only in the knockdown group for all three SUMO paralogs as soon as 3 dpf (Figure 2A and Supplementary information, Table S1 ). At around 7 dpf, the injected embryos died. A reduction in the sizes of brain and eyes, and malformations in the jaw were observed (Figure 2A, a-d) . Surprisingly, the structures of the trunk, tail and otic placode remained unaffected. Hematoxylin-eosin staining showed a relative normal gross structure of eyes, but with reduced cell number within each structural cell layer ( npg cian blue staining demonstrated that the first to fourth pair of gill arches were dramatically reduced or absent. Interestingly, the fifth pair was still present (Figure 2A , e-h). Chondrocytes of gill arches of SUMO-deficient embryos were much larger compared to the control ones ( Figure 2A , e'-h'), suggesting that the cell cycle might be affected. Pairwise loss of SUMO1 and SUMO3, or SUMO2 and SUMO3 paralogs led to a much lower incidence of developmental defects (Supplementary information, Table S1 ). Lower incidence and less severe defects of double SUMO knockdown morphants were probably due to the fact that there were less apoptosis events com- populations from the head region of SUMO paralogdeficient embryos had a significant higher fraction of cells in the G 2 /M-phase, which was not the case for the cells from trunk and tail ( Figure 2B , e-h). Furthermore, using dominant negative non-conjugation SUMO mutants (SUMOΔGG-GFP), we found that cells expressing SUMO2ΔGG-GFP and SUMO3ΔGG-GFP also accumulated in the G 2 /M-phase (data not shown).
Rescue experiments suggest that developmental defects are specifically caused by the loss of SUMO paralogs
To confirm that the developmental defects of the SUMO paralog-deficient morphants were specifically due to the loss of SUMO expression, a series of rescue experiments were carried out. Full-length zebrafish and human SUMO paralog mRNAs were co-injected with (Figure 2A , c, g and k), more interestingly, each individual SUMO paralog, either of zebrafish or human origin, was also able to restore a normal phenotype, with SUMO2 and SUMO3 being the most efficient ( Table 1) . A sumoylation consensus Ψ-K-X-D/E motif also exists in SUMO2 and SUMO3, but not in SUMO1, suggesting that SUMO2 and SUMO3 may form poly-SUMO chains [27] . To test if this potential poly-SUMO formation lysine is required for SUMO rescue function in vivo, we constructed a zebrafish SUMO2 mutant where the conserved lysine 11 was changed to glutamine (K11E). Interestingly, this mutant had the same rescue efficiency as the wild-type (wt) one, suggesting that the potential poly-sumoylation of SUMO2 itself is not required in this setting ( Table 1 ). The unstructured stretch of first 21 N-terminal amino acids of SUMO is not conserved in ubiquitin. A delta N21 SUMO2 mutant was constructed and used for rescue assay. Interestingly, the mutant was unable to restore the normal phenotype. It was also reported that charge-reversal mutations of K33/35/42 within a highly conserved surface of SUMO dramatically abrogated its repressive effect [28, 29] . Consistent with this, our zebrafish SUMO2 K33/35/42E mutant had completely lost its rescue function, despite that the mutant could still efficiently conjugate to substrates (Table 1 and data not shown).
cDNA microarray and real-time PCR analysis revealed specific activation of the p53 pathway in SUMO paralogdeficient morphants
To further investigate the possible molecular mechanisms underlying the developmental defects caused by loss of all three SUMO paralogs, cDNA microarray analysis was performed on Affymetrix GeneChip Zebrafish Genome Array. About 100 genes were found upregulated or downregulated by at least twofold. Genes involved in the development of neurons and eyes, for instance, crx [30] , rcv1 [31] , neurod [32] , vsx1 [33] , rho [34] , atoh2a [35] and rorab [36] were found downregulated (data not shown). Interestingly, the tumor suppressor p53 signaling pathway was found to be activated. Quantitative realtime PCR analysis further demonstrated that most p53 target genes, including p21, mdm2 and cyclin G1, were upregulated in a time-dependent manner with peaks appearing at 24 to 48 hpf ( Figure 3A) . Moreover, using isoform-specific primers, real-time PCR analysis showed that it was the truncated form of p53 (Δ113p53), lacking the transactivation domain and part of the DNA-binding domain, but not the full-length p53 (FL p53) that was drastically upregulated (Figure 3A and 3B) . While bax was marginally activated, significant activation of other target genes were further confirmed using mRNAs isolated from morphants head region ( Figure 3B ). Importantly, Δ113p53 was not induced by extinction of individual SUMO paralog ( Figure 3B ).
Given the fact that the p53 pathway was activated and Δ113p53 was strongly upregulated in embryos deficient for all three SUMO paralogs, MO against FL p53 or Δ113p53 was co-injected with the three SUMO paralog MOs. Interestingly, FL p53 MO eradicated apoptotic cells in the head region and alleviated morphological developmental defects ( Figure 4A and 4B) , and diminished the activation of p53 target gene transcription ( Figure  3B ). As a result, the embryos survived and continued to develop normally. On the contrary, Δ113p53 MO caused enhanced activation of p53 target genes and resulted in more severe and earlier onset of embryonic developmental defects due to cell apoptosis ( Figure 3B , 4A and 4B). Consistent with a previous report [37] , we also demonstrated that Δ133p53, the human counterpart of zebrafish Δ113p53, was a possible p53 direct target gene driven by an alternative internal promoter within intron 4 of human p53 (data not shown). Luciferase assays were performed on a series of p53 target gene promoters, including mdm2, fas and PIG3. While Δ133p53 by itself could not activate these promoters, it attenuated the transactivation effect of FL p53 in a dose-dependent manner ( Figure 4C -E). Then we questioned if Δ133p53 may regulate FL p53 activity through its oligomerization-dependent protein stabilization effect, as the oligomerization domain was still retained in Δ133p53. Pulse chase result showed that the turnover rate of p53 was not affected by Δ133p53 ( Figure 4F ). It has been reported that p53 itself could be sumoylated on K386, and the consequence of p53 sumoylation on transcription regulation was still under debate [38] [39] [40] [41] . Our luciferase assay results showed no significant difference between wt p53 and p53 K386R on the tested promoters (Supplementary information, Figure  S4 ). In addition, turnover rate of the two proteins was quite similar (data not shown). These data suggest that hypo-sumoylation of p53 may not have a direct impact on its transactivation.
Discussion
Sumoylation and desumoylation have essential effects on a variety of biological events and involve a multienzyme process. It has been reported that loss of the unique E2 conjugating enzyme Ubc9 is embryonic lethal in zebrafish [23] and mice [22] . In contrast, disruption of the E3 ligase PIAS family genes leads to modest defects in mice. PIASx-mutant mice have reduced testis weight and an increased rate of apoptosis [42] , PIASy-deficient mice display modest defects in IFN and Wnt signaling pathways [43, 44] and PIAS1 knockout mice do not have histological defects [45] . These results suggest that there is functional redundancy among SUMO E3 ligase PIAS family members during mouse development. Inactivation of the desumoylating enzyme, SENP1, causes an increase in the level of SUMO1 conjugation but not in that of SUMO2 or SUMO3, and results in prenatal lethality in mice [46] . SENP1 knockout mice display severe fetal anemia in midgestation [47] . But up to date, the respective biological function of each SUMO paralog in the early embryonic development remains unknown. Here, we report that similar to the loss of Ubc9, simultaneous knockdown of all three SUMO paralogs was lethal in most morphants. It is worth noting that the loss of Ubc9 leads to a higher percentage of defective embryos than does the loss of three SUMO paralogs (97.5% vs 84.9%). This observation may be explained, in part, by the fact that reduction of Ubc9 by MO is more efficient than that of SUMO paralogs (Supplementary information, Figure  S2B ). Interestingly, we find that loss of single paralog or pairwise loss of SUMO1 and SUMO2 leads to no overt defect. SUMO1 and SUMO3, or SUMO2 and SUMO3 double-deficient embryos displayed a lower incidence and less severity of developmental defects, suggesting that a partial functional redundancy may exist between SUMO paralogs and that SUMO3 might have a more critical or broader spectrum of substrates during the early embryonic development. In accordance with these findings, we demonstrate that the developmental defects associated with loss of the three SUMO paralogs could be rescued by any single SUMO paralog. The rescue effect of SUMO2 and SUMO3 is much better than that of SUMO1, again arguing for the importance of SUMO2 and SUMO3. Although we do not have the direct in vivo evidence that different paralogs can be used interchangeably, our findings suggest that there is a significant functional redundancy of SUMO paralogs and that the functions of one specific SUMO can be compensated by other paralogs. Our observation is further supported by the recent findings that SUMO1 is dispensable in mouse development [25] and that SUMO1 and SUMO2 are functionally redundant genes in Arabidopsis as only double-homozygous mutants in embryo are lethal [48] .
Sumoylation of transcription factors normally leads to transcriptional repression through the interaction with co-repressors such as Daxx or HDACs. A basic residuerich region of SUMO (K33, K35, K42, R50) defines the interaction surface for the co-repressors and accounts for the inhibitory properties of SUMO [28, 29] . These sites are highly conserved in all zebrafish and human SUMO paralogs. In our rescue experiments, the zebrafish SUMO2 K33/35/42E charge-reversed mutant failed to function, further emphasizing the critical role of these residues for SUMO function in vivo. In SUMO2 and SUMO3, the presence of a potential sumoylation consensus sequence could allow SUMO2 and SUMO3 to form poly-SUMO chain [27] . Though we could not rule out the possibility that other lysine residues may also be used for chain formation, the SUMO2 K11E consensus sequence mutant has no impact on the rescue effect, suggesting that the possible poly-SUMO chain formation on this potential site might not be required for its in vivo function in this setting. Incapability of the SUMO2 delta N21 mutant to restore the normal phenotype suggests that the N-terminal unstructured region of SUMO, which is not conserved in ubiquitin, may possess yet unidentified properties required for its biological function.
In our experiments, we show that the p53 pathway was activated in morphants deficient for all three SUMO paralogs. It has been reported that the MO knockdown technology may elicit undesirable off-target effects and that the major off-target effect is mediated through p53 activation accompanied by diagnostic transcription of Δ113p53 [49] . Our results do not support this scenario. First, as mentioned above, knockdown of single SUMO paralog did not lead to any developmental defects and p53 activation. Second, single SUMO paralog, of either zebrafish or human origin, could specifically reverse the phenotype caused by SUMO deficiency, suggesting that the developmental defects are strictly SUMO-related. Finally, MO targeting FL p53 could alleviate cell apoptosis and rescue morphological defects associated with the loss of SUMO paralogs.
We also found that the dominant negative isoform Δ113p53 was drastically upregulated, and Δ113p53 MO caused further activation of p53 target genes and earlier onset of more severe embryonic developmental defects. Consistent with this, it has been very recently reported that zebrafish Δ113p53 is a p53 target gene and antagonizes p53 apoptotic activity in vivo through Bclxl activation [50] .
It is still unclear how loss of SUMO paralogs activates the p53 pathway. This is unlikely due to the direct consequence of hypo-sumoylation of p53 protein caused by SUMO knockdown, as the p53 sumoylation-defective mutant (p53 K386R) shares similar transactivation and protein stability properties with the wt one. This is not surprising since only a limited fraction of p53 is sumoylated in vivo. We favor the hypothesis that p53 activation could be a secondary effect resulting from the loss of SUMOs. A plausible mechanism is suggested by the recent findings that SUMO paralogs are involved in the mitotic process of mammalian cells, and sumoylation is a key regulator of cell cycle [51] . Inhibition of sumoylation may block sister chromatid segregation and cause cell cycle arrest. Cells may eventually succumb to a secondary, p53-dependent apoptotic cell death.
Taken together, our in vivo probing of the SUMO system in zebrafish embryo demonstrates that SUMO extinction triggers p53 activation and cell death, but that the three SUMOs are functionally redundant. SUMO K11 chain formation appears to be dispensable for early developmental processes.
Materials and Methods
Fish maintenance
Zebrafish maintenance and staging were performed as described previously [52] .
Generation of constructs
SUMOs and Ubc9 were amplified by RT-PCR with indicated primes for either WISH assay or rescue assay (Table S2) , and cloned into pCS2 + vector. For MO specificity assay, a 5′ fragment of each SUMO paralog covering the ATG site was amplified with indicated primers (Table S2 ) and cloned in frame with egfp into pCS2 + vector. The zebrafish SUMO2 K11E and K33/35/42E mutants were generated by QuickChange Site-Directed Mutagenesis Kit (Stratagene) with indicated primers (Table S2 ). The zebrafish SUMO2ΔN21 was generated by PCR with indicated primers (Table  S2 ). The human p53 intron 4 sequences were amplified from human genomic DNA with indicated primers (Table S2) . Human Δ133p53 was cloned into pSG5 expression vector with indicated primers (Table S2) .
Whole-mount in situ hybridization
Digoxigenin-labeled or fluorescein-labeled antisense RNA probes were transcribed from linearized cDNA constructs using T3 or T7 polymerase (Roche). Whole-mount in situ hybridization was performed as described previously [53] . The probes were detected using alkaline phosphatase-coupled anti-digoxigenin Fab fragment antibody (Roche) or anti-fluorescein Fab fragment antibody (Roche) with BCIP/NBT staining (Vector Laboratories) or Fast red staining (Roche).
MOs and mRNAs microinjection
MOs were purchased from Gene Tools. SUMO1 MO 5′-GTC TCC GTG TCT GAC ATG ATA TTC C-3′; SUMO2 MO 5′-CAT GGT TAT TGT ATT TGC GCT TCT C-3′; SUMO3 MO 5′-TAG GCT TGT CTT CGG ACA TTT TTG C-3′; Ubc9 MO 5′-TCA GAG CAA TGC CAG ACA TGA CCA C-3′; p53 MO 5′-TCT TGG CTG TCG TTT TGC GCC ATT G-3′; △113p53 MO 5′-GCA ACG TCC ACC ACC ATT TGA ACG G-3′; mismatch MO 5′-GTG TCC CTG TCT CAC ATC ATA TAC C-3′. 
Immunoblotting
Embryos were harvested at indicated time points and de-yolked as described previously [54] . Western blotting was performed with rabbit anti-SUMO1 (Zymed), rabbit anti-SUMO2/3 (Zymed), rabbit anti-Ubc9 (Zymed), goat anti-p53 (Santa Cruz) and rabbit antiactin (Sigma) antibodies. The blots were detected by SuperSignal West Pico Substrate (Pierce). P53 pulse chase assay was carried out in H1299 cells. Cells were transfected with different p53 constructs and treated with 50μg/ml cycloheximide (CHX) 24 h after transfection. Cells were harvested at indicated time points and subjected to immunoblotting analysis.
Histology and alcian blue staining
Embryos were fixed in 4% paraformaldehyde/PBS, dehydrated and embedded in paraffin. Specimens were cut into 4 µm sections that were stained with hematoxylin and eosin solution. Alcian blue staining was performed as described previously [49] .
TUNEL assay, phosphorylated histone H3 labeling and fluorescence-activated cell sorting analysis (FACS)
TUNEL was performed using the in situ Cell Death Detection Kit, TMR red (Roche) according to the manufacturer's recommendations. Briefly, embryos were dechorionated and fixed in 4% paraformaldehyde/PBS overnight, dehydrated and stored in methanol at −20 °C. After rehydration in PBS, embryos were permeabilized with 0.1% sodium citrate and 0.1% Triton X-100 for 15 min at room temperature and subjected to the TUNEL assay. Phosphorylated histone H3 labeling of fixed embryos was performed with the rabbit anti-phosphohistone H3 antibody (Santa Cruz) at 4 °C overnight and revealed with Alexa Fluor 488 goat anti-rabbit secwww.cell-research.com | Cell Research
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cDNA microarray and quantitative real-time PCR
RNA of injected embryos were extracted with RNeasy Mini Kit (Qiagen) according to the manufacturer's recommendations. Microarray assay was performed by Shanghai Biochip Co. Ltd. The quantitative real-time PCR was performed by a LightCycler 1.5 (Roche) following manufacturer's protocols, and the amount of transcribed cDNA was normalized to β-actin. The quantitative real-time PCR were performed with indicated primers (Table S3) .
Luciferase reporter assay
H1299 cells were transfected with indicated plasmid using Fu-GENE HD Transfection Reagent (Roche). Cells were harvested 48 h after transfection and luciferase activities were analyzed using the Dual Luciferase Reporter Assay Kit (Promega) according to the manufacturer's protocols. Luciferase activity was normalized to Renilla activity.
